[1]孙 澜,马吉芳,崔乃凡.慢性阻塞性肺疾病并发肺动脉高压患者血清CCL28，SDF-1 表达水平及临床意义[J].现代检验医学杂志,2023,38(01):140-146.[doi:10.3969/j.issn.1671-7414.2023.01.026]
　SUN Lan,MA Ji-fang,CUI Nai-fan.Expression of Serum CCL28 and SDF-1 in Patients with Chronic Obstructive Pulmonary Disease Complicated by Pulmonary Hypertension and Its Clinical Significance[J].Journal of Modern Laboratory Medicine,2023,38(01):140-146.[doi:10.3969/j.issn.1671-7414.2023.01.026]
点击复制

慢性阻塞性肺疾病并发肺动脉高压患者血清CCL28，SDF-1 表达水平及临床意义()
分享到：

《现代检验医学杂志》[ISSN:/CN:]

卷:
第38卷
期数:
2023年01期
页码:
140-146
栏目:
论著
出版日期:
2023-01-15

文章信息/Info

Title:
Expression of Serum CCL28 and SDF-1 in Patients with Chronic Obstructive Pulmonary Disease Complicated by Pulmonary Hypertension and Its Clinical Significance
文章编号:
1671-7414（2023）01-140-07
作者:
孙 澜; 马吉芳; 崔乃凡
（辽阳中心医院检验科，辽宁辽阳 111000）
Author(s):
SUN Lan;  MA Ji-fang;  CUI Nai-fan
(Department of Clinical Laboratory，Liaoyang Central Hospital, Liaoning Liaoyang 111000, China)
关键词:
慢性阻塞性肺疾病; 肺脉高压; 趋化因子; 基质细胞衍生因子-1; CC 趋化因子配体28
分类号:
R563；R392.11
DOI:
10.3969/j.issn.1671-7414.2023.01.026
文献标志码:
A
摘要:
目的 探讨慢性阻塞性肺疾病（chronic obstructive pulmonary disease ，COPD）并发肺动脉高压（pulmonaryhypertension ，PAH）患者血清CC 趋化因子配体28（CC chemokine ligand 28，CCL28）、基质细胞衍生因子-1（stromalcell-derived factor-1，SDF-1）表达水平及临床意义。方法 选取2019 年2 月～ 2021 年6 月辽阳中心医院收治的209例COPD 患者，分为PAH 组（n=39 例）和非PAH 组（n=170），根据平均肺动脉压（mean pulmonary artery pressure，mPAP）将PAH 组分为轻中度组（n=23）和重度组（n=16），选择同期53 例健康体检者为对照组。检测各组血清CCL28 和SDF-1 水平，采用 Logistic 回归分析COPD 并发PAH 发生的影响因素，受试者工作特征（ROC）曲线分析血清CCL28 和SDF-1 对COPD 并发PAH 的诊断价值。结果 PAH 组血清CCL28，SDF-1 水平分别为3.26±0.73pg/ml，135.26±23.16mg/L，高于非PAH 组（1.35±0.35pg/ml，68.12±17.14mg/L）和对照组（0.51±0.16pg/ml，21.02±6.59mg/L），差异均有统计学意义（F =539.772，525.459，均P ＜ 0.05）；重度组血清CCL28，SDF-1 水平分别为3.88±0.10pg/ml，140.88±10.05mg/L，高于轻中度组（2.83±0.26 pg/ml，131.35±6.43mg/L），差异有统计学意义（t=15.333，3.616，P ＜ 0.05）。Logistic 回归分析显示高COPD 急性发作次数、高mPAP 以及血清CCL28 和SDF-1 高表达是COPD 并发PAH的危险因素（P=0.000 ～ 0.003）。血清CCL28，SDF-1 诊断COPD并发PAH的曲线下面积（AUC）分别为0.697（95%CI：0.630 ～ 0.758），0.681（95%CI：0.614 ～ 0.744）；血清CCL28 和SDF-1 联合检测诊断COPD 并发PAH 的AUC 为0.937（95%CI：0.895 ～ 0.966），两者联合检测优于单独检测，差异有统计学意义（Z=6.116，5.562，P ＜ 0.001）。结论 COPD 并发 PAH 患者血清CCL28，SDF-1 水平均升高，是COPD 并发PAH 的危险因素，对于COPD 并发 PAH 的诊断具有重要参考价值。
Abstract:
Objective To investigate the expression of CC chemokine ligand 28 (CCL28) and stromal cell-derived factor-1 (SDF-1) in patients with chronic obstructive pulmonary disease (COPD) and pulmonary hypertension (PAH) and their clinical significance. Methods 209 patients with COPD admitted to the Liaoyang Central Hospital from February 2019 to June 2021 were selected and divided into PAH group (n=39 ) and non PAH group (n=170 ). PAH group was divided into mild to moderate group (n=23 ) and severe group (n=16 ) according to the mean pulmonary artery pressure (mPAP). 53 healthy people in the same period were selected as the control group.The levels of serum CCL28 and SDF-1 were detected in each group. The influencing factors of COPD complicated with PAH were analyzed by logistic regression. The diagnostic value of serum CCL28 and SDF-1 for COPD complicated with PAH was analyzed by the ROC curve. Results Serum CCL28 and SDF-1 levels in PAH group were 3.26 ± 0.73pg/ml, 135.26 ± 23.16mg/L, respectively， higher than those in non PAH group (1.35±0.35pg/ml, 68.12±17.14mg/L) and control group (0.51±0.16pg/ml, 21.02±6.59mg/L), and the differences was statistically significant (F=539.772, 525.459, all P<0.05). Serum CCL28 and SDF-1 levels in severe group were 3.88 ± 0.10 pg/ml, 140.88 ± 10.05 mg/L, respectively，higher than those in mild and moderate group (2.83 ± 0.26 pg/ml, 131.35 ± 6.43 mg/L)，and the differences was statistically significant (t=15.333, 3.616, P<0.05).Logistic regression analysis showed that high number of acute exacerbations of COPD, high mPAP, high expression of serum CCL28 and SDF-1 were risk factors for COPD complicated with PAH (P=0.000 ～ 0.003).The area under the curve(AUC) of serum CCL28 and SDF-1 in diagnosis of COPD complicated with PAH was 0.697 (95%CI：0.630 ～ 0.758) and 0.681 (95%CI：0.614 ～ 0.744), respectively, The AUC of combined detection of serum CCL28 and SDF-1 in the diagnosis of COPD complicated with PAH was 0.937 (95%CI：0.895 ～ 0.966), and the combined detection was superior to the single detection, with a statistically significant difference (Z=6.116, 5.562, P<0.001).Conclusion The levels of serum CCL28 and SDF-1 in patients with COPD complicated with PAH were both elevated, which would be risk factors for COPD complicated with PAH and has important reference value for the diagnosis of COPD complicated with PAH.

参考文献/References:

[1] FANG Liwen, GAO Pei, BAO Heling, et al. Chronic obstructive pulmonary disease in China: A nationwide prevalence study[J]. The Lancet Respiratory Medicine,2018, 6(6): 421-430.
[2] M A R O N B , A B M A N S H , E L L I O T T C G, e t a l . Pulmonary arterial hypertension:diagnosis,treatment,and novel advances[J]. American Journal of Respiratory and Critical Care Medicine,2021, 203(12): 1472-1487.
[3] 陈德才，赵乐. 血清肌肉生长抑制素和肌肉环指蛋白-1 对慢性阻塞性肺疾病急性加重期并发肺动脉高压的预测价值[J]. 中华实用诊断与治疗杂志，2021,35(1): 40-43.
CHEN Decai, ZHAO Le. Values of serum myostatin and MuRF-1 to the prediction of pulmonary hypertension in patients with acute exacerbation of chronic obstructive pulmonary disease [J]. Journal of Chinese Practical Diagnosis and Therapy, 2021,35 (1):40-43.
[4] MAMAZHAKYPOV A , VISWANATHAN G, LAWRIE A, et al. The role of chemokines and chemokine receptors in pulmonary arterial hypertension[J]. British Journal of Pharmacology, 2021,178(1): 72-89.
[5] HUANG Junqiong, YUE Huan, JIANG Tao, et al. IL-31 plays dual roles in lung inflammation in an OVAinduced murine asthma model[J]. Biology Open, 2019,8(1): bio036244..
[6] YUAN Ke, LIU Yu, ZHANG Yue, et al. Mural cell SDF1 signaling is associated with the pathogenesis of pulmonary arterial hypertension[J]. American Journal of Respiratory Cell and Molecular Biology, 2020,62(6): 747-759.
[7] 中华医学会呼吸病学分会慢性阻塞性肺疾病学组.慢性阻塞性肺疾病诊治指南(2013 年修订版)[J]. 中华结核和呼吸杂志, 2013, 36(4): 255-264.
Chronic Obstructive Pulmonary Disease Group of Chinese Thoracic Society. Guidelines for the diagnosis and management of chronic obstructive pulmonary disease (revised version 2013) [J]. Chinese Journal of Tuberculosis and Respiratory Diseases, 2013, 36(4):255-264.
[8] 中华医学会心血管病学分会肺血管病学组，中华心血管病杂志编辑委员会. 中国肺高血压诊断和治疗指南2018[J]. 中华心血管病杂志, 2018, 46(12): 933-964.
Working Group on Pulmonary Vascular Diseases of Chinese Society of Cardiology of Chinese Medical Association, Editorial Board of Chinese Journal of Cardiology. Chinese guidelines for the diagnosis and treatment of pulmonary hypertension 2018 [J]. Chinese Journal of Cardiology,2018,46 (12): 933-964.
[9] 毛文君，陈静瑜，郑明峰，等. 肺动脉高压对等待肺移植的慢性阻塞性肺疾病患者预后的影响[J]. 中华器官移植杂志，2018，39(9): 553-558.
MAO Wenjun，CHEN Jingyu，ZHENG Mingfeng，et al. Influence of pulmonary hypertension on patients with advanced chronic obstrnctive pulmonary disease prior to lung transplantation [J]. Chinese Journal of Organ Transplantation,2018,39(9):553-558.
[10] 王凤燕, 张冬莹, 梁振宇, 等. 面向全科医生的《慢性阻塞性肺疾病诊治指南(2021 年修订版)》解读[J].中国全科医学, 2021, 24(29): 3660-3663, 3677.
WANG Fengyan，ZHANG Dongying，LIANG Zhenyu, et al. Interpretation of guideline for the diagnosis and treatment of COPD(2021 revision) for General Practitioners [J]. Chinese General Practice, 2021, 24(29): 3660-3663,3677.
[11] 艾月琴, 路东明, 张文娟, 等. AECOPD 患者并发肺动脉高压的危险因素分析[J]. 医学临床研究，2018，35(9): 1755-1757.
AI Yueqin，LU Dongming，ZHANG Wenjuan，et al.Risk factors of pulmonary hypertension in AECOPD patients[J].Journal of Clinical Research, 2018,35(9):1755-1757.
[12] 曹秀丽, 宫志鹏, 康玉英, 等. 炎性因子与慢性阻塞性肺疾病并发肺动脉高压的相关性研究[J]. 中国煤炭工业医学杂志，2020，23(1): 99-103.
CAO Xiuli, GONG Zhipeng, KANG Yuying, et al.Study on the relationship between inflammatory factors and chronic obstructive pulmonary disease complicated with pulmonary hypertension [J]. Chinese Journal of Coal Industry Medicine,2020,23(1):99-103.
[13] ANDERSEN K H, ANDERSEN C B, GUSTAFSSON F, et al. Pulmonary venous remodeling in COPDpulmonary hypertension and idiopathic pulmonary arterial hypertension[J]. Pulmonary Circulation, 2017,7(2): 514-521.
[14] WANG Pengfei, QI Xiangbei, XU Guohui, et al.CCL28 promotes locomotor recovery after spinal cord injury via recruiting regulatory T cells[J]. Aging, 2019,11(18): 7402-7415.
[15] BURKHARDT A M, PEREZ L A, USHACH I , e t al. CCL28 is involved in mucosal IgA responses,olfaction,and resistance to enteric infections[J]. Journal of Interferon & Cytokine Research, 2019, 39(4): 214-223.
[16] KARNEZIS T, FARNSWORTH R H, HARRIS N C,et al. CCL27/CCL28-CCR10 chemokine signaling mediates migration of lymphatic endothelial cells[J].Cancer Research, 2019, 79(7): 1558-1572.
[17] LIU Bingchun, WEI Chunyan. Hypoxia induces overexpression of CCL28 to recruit Treg cells to enhance angiogenesis in lung adenocarcinoma[J].Journal of Environmental Pathology, Toxicology and Oncology, 2021, 40(1): 65-74.
[18] JOHN A E, THOMAS M S, BERLIN A A, et al.Temporal production of CCL28 corresponds to eosinophil accumulation and airway hyperreactivity in allergic airway inflammation[J]. American Journal of Pathology, 2005, 166(2): 345-353.
[19] 陈霏，王碧. 血清PDGF 及SDF-1 水平与急性脑梗死患者脑侧支循环建立的相关性研究[J]. 现代检验医学杂志, 2020, 35(1): 82-85.
CHEN Fei,WANG Bi. Study on the correlation between levels of MMP-9 and SDF-1 in serum and the establishment of cerebral collateral circulation in patients with acute cerebral infarction [J]. Journal of Modern Laboratory Medicine,2020,35(1):82-85.
[20] HENROT P, PREVEL R, BERGER P, e t a l . Chemokines in COPD:from implication to therapeutic use[J]. International Journal of Molecular Sciences,2019, 20(11): 2785.
[21] SHEN Wen, WENG Zhiyin，FAN Minjuan，et al. Mechanisms by which the MBD2/miR-301a-5p/CXCL12/CXCR4 pathway regulates acute exacerbations of chronic obstructive pulmonary disease[J]. Int J Chron Obstruct Pulmon Dis，2020，15:2561-2572.
[22] ZHANG Tingting, KAWAGUCHI N, YOSHIHARA K, et al. Silibinin efficacy in a rat model of pulmonary arterial hypertension using monocrotaline and chronic hypoxia[J]. Respiratory Research, 2019, 20(1): 79.
[23] WEI Liuping, ZHANG Bo, CAO Weiwei, et al.Inhibition of CXCL12/CXCR4 suppresses pulmonary arterial smooth muscle cell proliferation and cell cycle progression via PI3K/Akt pathway under hypoxia[J].Journal of Receptor and Signal Transduction Research,2015, 35(4): 329-339.
[24] YI Dan, LIU Bin, WANG Ting, et al. Endothelial autocrine signaling through CXCL12/CXCR4/FoxM1 axis contributes to severe pulmonary arterial hypertension[J]. International Journal of Molecular Sciences, 2021, 22(6): 3182.

相似文献/References:

[1]邱淑佳.慢性阻塞性肺疾病患者血清LCN1,LCN2的表达水平及临床意义[J].现代检验医学杂志,2017,32(06):67.[doi:10.3969/j.issn.1671-7414.2017.06.001]
　QIU Shu-jia.Expression Levels of Serum LCN1 and LCN2 in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease and Its Clinical Significance[J].Journal of Modern Laboratory Medicine,2017,32(01):67.[doi:10.3969/j.issn.1671-7414.2017.06.001]
[2]杜 洁a,朱 娜b,李红艳a,等.幽门螺杆菌感染对慢性阻塞性肺疾病血气分析及肺功能的影响[J].现代检验医学杂志,2017,32(06):99.[doi:10.3969/j.issn.1671-7414.2017.06.001]
　DU Jiea,ZHU Nab,LI Hong-yana,et al.Effect of Helicobacter Pylori Infection on Blood Gas Analysis and Pulmonary Function in Patients with Chronic Obstructive Pulmonary Disease[J].Journal of Modern Laboratory Medicine,2017,32(01):99.[doi:10.3969/j.issn.1671-7414.2017.06.001]
[3]李若倩,刘　云,李若然.外周血红细胞分布宽度和超敏C- 反应蛋白水平检测在慢性阻塞性肺疾病诊断中的价值分析[J].现代检验医学杂志,2020,35(03):123.[doi:10.3969/j.issn.1671-7414.2020.03.033]
　LI Ruo-qian,LIU Yun,LI Ruo-ran.Value of Detecting Peripheral Blood Red Blood Cell Distribution Width and High Sensitivity C Reactive Protein in the Diagnosis of Chromic Obstructive Pulmonary Disease[J].Journal of Modern Laboratory Medicine,2020,35(01):123.[doi:10.3969/j.issn.1671-7414.2020.03.033]
[4]陈元菁,艾红军,王湘云,等.COPD 患者线粒体功能及代谢水平变化检测与骨骼肌功能障碍的相关性研究[J].现代检验医学杂志,2020,35(06):25.[doi:doi:10.3969/j.issn.1671-7414.2020.06.007]
　CHEN Yuan-jing,AI Hong-jun,WANG Xiang-yun,et al.Study on the Correlation between Changes Detection in Mitochondrial Function,Metabolic Level and Skeletal Muscle Dysfunction Inpatients with COPD[J].Journal of Modern Laboratory Medicine,2020,35(01):25.[doi:doi:10.3969/j.issn.1671-7414.2020.06.007]
[5]王　苗,张　萍.COPD患者血清 Cav-1及 CXCL12水平检测与并发肺动脉高压的相关性研究[J].现代检验医学杂志,2021,36(01):29.[doi:10.3969/j.issn.1671-7414.2021.01.008]
　WANG Miao,ZHANG Ping.Correlation between Levels of Cav-1 and CXCL12 in Serum and Pulmonary Hypertension in Patients with COPD[J].Journal of Modern Laboratory Medicine,2021,36(01):29.[doi:10.3969/j.issn.1671-7414.2021.01.008]
[6]闫海燕,杨云秀,杨云华,等.慢性阻塞性肺疾病患者 Nrf2 基因多态性与肺功能及临床病情判断的相关性研究[J].现代检验医学杂志,2021,36(03):27.[doi:10.3969/j.issn.1671-7414.2021.03.007]
　YAN Hai-yan,YANG Yun-xiu,YANG Yun-hua,et al.Study on Relevance of Nrf2 Gene Polymorphism with Pulmonary Functionand Clinical Condition Judgment in Patients with Chronic ObstructivePulmonary Disease[J].Journal of Modern Laboratory Medicine,2021,36(01):27.[doi:10.3969/j.issn.1671-7414.2021.03.007]
[7]胡小燕,郑　晓,嵇华夏,等.血清 PCT 与 BNP 水平联合检测对慢性阻塞性肺疾病急性加重期并发心力衰竭的临床诊断价值[J].现代检验医学杂志,2021,36(03):128.[doi:10.3969/j.issn.1671-7414.2021.03.029]
　HU Xiao-yan,ZHENG Xiao,JI Hua-xia,et al.Clinical Diagnostic Value of Combined Detection of Serum PCT and BNPLevels in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease Complicated with Heart Failure[J].Journal of Modern Laboratory Medicine,2021,36(01):128.[doi:10.3969/j.issn.1671-7414.2021.03.029]
[8]陈志勇a,罗世林a,张　健b,等.慢阻肺患者血清IL-17，IL-27和IL-33水平表达及与不同临床分期FeNO和肺功能的相关性研究[J].现代检验医学杂志,2021,36(04):152.[doi:10.3969/j.issn.1671-7414.2021.04.033]
　CHEN Zhi-yonga,LUO Shi-lina,ZHANG Jianb,et al.Expression of Serum IL-17, IL-27 and IL-33 in Patients with ChronicObstructive Pulmonary Disease and Its Correlation with FeNO and LungFunction in Different Clinical Stages[J].Journal of Modern Laboratory Medicine,2021,36(01):152.[doi:10.3969/j.issn.1671-7414.2021.04.033]
[9]王述红,邱　容,罗晓斌,等.慢性阻塞性肺疾病患者血气分析指标，FeNO，EOS%水平变化与CAT评分的相关性研究[J].现代检验医学杂志,2021,36(04):156.[doi:10.3969/j.issn.1671-7414.2021.04.034]
　WANG Shu-hong,QIU Rong,LUO Xiao-bin,et al.Correlation between Changes of Blood Gas Analysis Indexes, FeNO, EOS%and CAT Score in Patients with Chronic Obstructive Pulmonary Disease[J].Journal of Modern Laboratory Medicine,2021,36(01):156.[doi:10.3969/j.issn.1671-7414.2021.04.034]
[10]龙借帆a,李　翠a,高元标a,等.联合检测血清SIRT1和CTRP5水平对慢性阻塞性肺疾病急性加重期患者预后的预测价值研究[J].现代检验医学杂志,2022,37(03):162.[doi:10.3969/j.issn.1671-7414.2022.03.034]
　LONG Jie-fana,LI Cuia,GAO Yuan-biaoa,et al.Prognostic Value of Combined Detection of Serum SIRT1 and CTRP5 Levels in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease[J].Journal of Modern Laboratory Medicine,2022,37(01):162.[doi:10.3969/j.issn.1671-7414.2022.03.034]

备注/Memo

备注/Memo:
基金项目：辽宁省科技攻关项目（2019225018）。
作者简介：孙澜（1982-），女，学士，主治医师，研究方向：临床检验，E-mail:sl19821226@163.com。
更新日期/Last Update: 2023-01-15